OriGene Publishes Landmark Paper on Revolutionary Proteome Platform for Antibody Specificity Test
January 7, 2013
ROCKVILLE, MD -- OriGene Technologies, Inc. (“OriGene”), one of the industry leaders in producing genome wide products for research and diagnostic applications, has brought the antibody field one step closer to identifying and developing ultra-specific monoclonal antibodies. Specificity of antibodies for research or clinical applications is of critical importance and therefore it is a "must" [...]
Risa Stack to Join GE Healthymagination Team
January 7, 2013
Menlo Park, CA – Kleiner Perkins Caufield & Byers (KPCB) announced today that Risa Stack, PhD., a long time partner at KPCB, has been named General Manager of GE’s Emerging Health Innovations, reporting to Sue Siegel, CEO of healthymagination. Stack has served for two years on the advisory board for healthymagination – GE’s $6 billion [...]
Bruker Corporation Appoints Joshua Young as Vice President of Investor Relations
January 7, 2013
BILLERICA, Mass.-- Bruker Corporation (NASDAQ: BRKR) today announced that it has appointed Joshua Young as Vice President of Investor Relations. Young will succeed Stacey Desrochers who will continue as a key member of Bruker's finance organization and will focus full-time on managing Bruker's worldwide Treasury operations. Desrochers was instrumental in strengthening Bruker's investor relations and [...]
Flat Surface Controlled Temperature T Plates for Live-Cell Imaging
January 7, 2013
Warner Instruments is pleased to introduce Okolab T Plates, round heated plates with a built in temperature sensor, compatible with any microscope. • Suitable for inverted microscopes • Ideal for short term experiments • Glass and metal versions available • Touch screen interface temperature controller The T Plate fits into microscope XY stages with circular [...]
January 7, 2013
Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today launched the Mobius® FlexReady Solution with Smart Flexware® Assemblies for tangential flow filtration (TFF). The fully-automated system is ready to implement and features scalable, industry-leading filtration technologies for unmatched performance and operational flexibility. Unlike traditional single-use processing systems, this modular [...]
TTP Labtech launches acumen® hci for rapid multiplexed imaging
January 7, 2013
TTP Labtech has announced the release of the acumen® hci (high content imaging) system, developed for researchers who are looking to increase the productivity of their high throughput imaging. Replacing the acumen eX3, the new acumen hci is the fastest imager on the market for multiplex assays in up to 1536-well plates, and the new [...]
Pall Corporation Names R. Brent Jones Treasurer
January 7, 2013
PORT WASHINGTON, N.Y., - Pall Corporation (NYSE:PLL) announced today that R. Brent Jones has been appointed Treasurer, effective immediately. Mr. Jones, who joined Pall as VP of Finance in May of 2012, will continue to serve in that role, overseeing Treasury, Corporate Financial Planning and Investor Relations. Larry Kingsley, President and CEO commented, “Since joining [...]
January 7, 2013
Sunnyvale, CA & Helsinki – Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in [...]
MDx Enters into an Agreement with QIAGEN to Develop Molecular Tests
January 7, 2013
CAMBRIDGE, MASSACHUSETTS –— IMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. [...]
January 7, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone payments through 2015. Upon completion of the acquisition, Illumina [...]
